Variable | Characteristics | HR | 95% CI | P-value |
---|---|---|---|---|
SWVg–derived 19 miRNA signature: three groups | low risk group | 1 |  |  |
intermediate risk group | 1.80 | 1.30-2.50 | 4.00E-04 | |
high risk group | 5.39 | 2.68-10.84 | 2.37E-06 | |
tumor residual disease | 1-10 mm | 1 | Â | Â |
11-20 mm | 0.98 | 0.53-1.78 | 0.94 | |
>20 mm | 0.93 | 0.64-1.36 | 0.72 | |
No macroscopic disease | 0.50 | 0.31-0.81 | 4.78E-03 | |
tumor stage | low (stage I, II) | 1 | Â | Â |
high (stage III, IV) | 1.87 | 0.74-4.72 | 0.19 | |
tumor grade | low (grade 1, 2) | 1 | Â | Â |
high (grade 3, 4) | 1.41 | 0.90-2.20 | 0.14 |